Published in BMC Med on April 20, 2011
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol (2012) 2.52
Microvascular brain pathology and late-life motor impairment. Neurology (2013) 1.64
Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology (2015) 1.53
The dynamic relationship between physical function and cognition in longitudinal aging cohorts. Epidemiol Rev (2013) 1.49
Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol (2014) 1.04
Incident parkinsonism in older adults without Parkinson disease. Neurology (2016) 1.04
Association of brain pathology with the progression of frailty in older adults. Neurology (2013) 1.01
Terminal decline in motor function. Psychol Aging (2012) 0.97
Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci (2014) 0.94
Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease. Mov Disord (2012) 0.92
Total daily activity declines more rapidly with increasing age in older adults. Arch Gerontol Geriatr (2013) 0.92
Loss of motor function in preclinical Alzheimer's disease. Expert Rev Neurother (2011) 0.91
Parkinsonism in Older Adults and Its Association With Adverse Health Outcomes and Neuropathology. J Gerontol A Biol Sci Med Sci (2015) 0.91
Associations between quantitative mobility measures derived from components of conventional mobility testing and Parkinsonian gait in older adults. PLoS One (2014) 0.90
Poor Gait Performance and Prediction of Dementia: Results From a Meta-Analysis. J Am Med Dir Assoc (2016) 0.84
Cumulative exposure to lead and cognition in persons with Parkinson's disease. Mov Disord (2012) 0.80
The resveratrol-enriched rice DJ526 boosts motor coordination and physical strength. Sci Rep (2016) 0.78
Antihypertensive and Statin Medication Use and Motor Function in Community-Dwelling Older Adults. J Am Med Dir Assoc (2015) 0.75
Harm avoidance is associated with progression of parkinsonism in community-dwelling older adults: a prospective cohort study. BMC Geriatr (2014) 0.75
Change in motor function and adverse health outcomes in older African-Americans. Exp Gerontol (2015) 0.75
Motor Function Is Associated With Incident Disability in Older African Americans. J Gerontol A Biol Sci Med Sci (2015) 0.75
Subtle motor disturbances in PREDICT-PD participants. J Neurol Neurosurg Psychiatry (2016) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci (2004) 12.46
Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol (1998) 10.23
A measure of primary sociobiological functions. Int J Health Serv (1976) 8.93
Parietal lobe: from action organization to intention understanding. Science (2005) 6.42
Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc (2004) 5.80
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Locomotor circuits in the mammalian spinal cord. Annu Rev Neurosci (2006) 4.64
Assignment of functional activations to probabilistic cytoarchitectonic areas revisited. Neuroimage (2007) 4.21
Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med (1996) 3.48
The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol (2006) 3.38
Relation of cognitive activity to risk of developing Alzheimer disease. Neurology (2007) 3.34
Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc (2007) 2.94
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2005) 2.59
Parkinsonian signs in subjects with mild cognitive impairment. Neurology (2005) 2.30
Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med (2007) 2.27
Motor learning in man: a review of functional and clinical studies. J Physiol Paris (2006) 2.23
Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2002) 2.13
A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. J Gerontol A Biol Sci Med Sci (2007) 1.83
Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc (2010) 1.78
Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology (2008) 1.59
Change in motor function and risk of mortality in older persons. J Am Geriatr Soc (2007) 1.57
Change in frailty and risk of death in older persons. Exp Aging Res (2009) 1.54
Spinal and brain control of human walking: implications for retraining of walking. Neuroscientist (2006) 1.52
The differential effect of PD and normal aging on early explicit sequence learning. Neurology (2003) 1.52
Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol (2005) 1.48
Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology (2005) 1.45
Physical activity and motor decline in older persons. Muscle Nerve (2007) 1.45
Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci (1999) 1.42
Cerebral correlates of motor imagery of normal and precision gait. Neuroimage (2008) 1.38
Pulmonary function, muscle strength, and incident mobility disability in elders. Proc Am Thorac Soc (2009) 1.31
The neural basis of the egocentric and allocentric spatial frame of reference. Brain Res (2006) 1.29
Physical activity and leg strength predict decline in mobility performance in older persons. J Am Geriatr Soc (2007) 1.23
Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol (2005) 1.04
Functional correlates of mild parkinsonian signs in the community-dwelling elderly: poor balance and inability to ambulate independently. Mov Disord (2006) 1.03
Early Parkinson's disease: longitudinal changes in brain activity during sequence learning. Neurobiol Dis (2009) 1.00
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology (2007) 9.27
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (2007) 8.10
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging (2002) 6.18
Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA (2002) 6.18
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00
Charting a dynamic DNA methylation landscape of the human genome. Nature (2013) 5.80
The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology (2005) 5.64
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol (2004) 5.11
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol (2007) 5.02
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res (2012) 4.91
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol (2003) 4.37
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med (2006) 4.00
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol (2002) 3.84
Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell (2013) 3.83
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc (2005) 3.68
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest (2012) 3.65
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol (2003) 3.56
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Overview and findings from the religious orders study. Curr Alzheimer Res (2012) 3.46
Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry (2007) 3.44
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol (2004) 3.39
The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol (2006) 3.38
Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis (2003) 3.36
Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA (2002) 3.19
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology (2006) 3.00
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron (2008) 2.99
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain (2007) 2.96
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging (2005) 2.79
Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol (2013) 2.78
Contribution of Alzheimer disease to mortality in the United States. Neurology (2014) 2.67
Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science (2011) 2.66
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology (2013) 2.59
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis (2009) 2.54
Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol (2012) 2.52
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet (2010) 2.51
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest (2004) 2.46
Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry (2007) 2.41
Three-dimensional locations and boundaries of motor and premotor cortices as defined by functional brain imaging: a meta-analysis. Neuroimage (2006) 2.40
Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol (2005) 2.38
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. J Clin Invest (2012) 2.33
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol (2002) 2.27
Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med (2007) 2.27
Association between late-life social activity and motor decline in older adults. Arch Intern Med (2009) 2.26
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol (2010) 2.20
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19